Back
Blueprint Medicines Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
BPMC
Blueprint Medicines
Last Price:
$88.67
Seasonality Move:
10.57%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.65 | Sell |
| 20-day SMA: | 90.3 | Sell |
| 50-day SMA: | 98.89 | Sell |
| 200-day SMA: | 97.04 | Sell |
| 8-day EMA: | 90.4 | Sell |
| 20-day EMA: | 91.43 | Sell |
| 50-day EMA: | 94.31 | Sell |
| 200-day EMA: | 94.01 | Sell |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.64 | Sell |
| Relative Strength Index (14 RSI): | 43.4 | Sell |
| Chaikin Money Flow: | 30105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.38 - 92.88) | Sell |
| Bollinger Bands (100): | (88.27 - 104.19) | Sell |
Blueprint Medicines Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 88.72 while BPMC 8-day simple moving average is 90.65, which is a Sell signal.
-
The stock price of BPMC is 88.72 while Blueprint Medicines 20-day SMA is 90.30, which makes it a Sell.
-
Blueprint Medicines 50-day simple moving average is 98.89 while BPMC share price is 88.72, making it a Sell technically.
-
BPMC stock price is 88.72 and Blueprint Medicines 200-day simple moving average is 97.04, creating a Sell signal.
BPMC Technical Analysis vs Fundamental Analysis
Sell
37
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a SellThe current Blueprint Medicines [BPMC] share price is $88.72. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Blueprint Medicines Stock Info
Market Cap:
5.7B
Price in USD:
88.72
Share Volume:
621.3K
Blueprint Medicines 52-Week Range
52-Week High:
121.90
52-Week Low:
80.68
Sell
37
Blueprint Medicines (BPMC)
is a Sell
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?The Blueprint Medicines stock price is 88.72 USD today.
-
Will BPMC stock go up or go down?Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators
-
Is Blueprint Medicines overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is overvalued.
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 88.72 while BPMC 8-day exponential moving average is 90.40, which is a Sell signal.
-
The stock price of BPMC is 88.72 while Blueprint Medicines 20-day EMA is 91.43, which makes it a Sell.
-
Blueprint Medicines 50-day exponential moving average is 94.31 while BPMC share price is 88.72, making it a Sell technically.
-
BPMC stock price is 88.72 and Blueprint Medicines 200-day simple moving average is 94.01, creating a Sell signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $2.69 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
-
BPMC Moving Average Covergence Divergence (MACD) indicator is -1.64, suggesting Blueprint Medicines is a Sell
-
Blueprint Medicines Relative Strength Index (RSI) is 43.4, which suggest Blueprint Medicines is oversold
-
The Bollinger Bands (25) for Blueprint Medicines is (88.38 - 92.88), which suggest Blueprint Medicines is a Sell
-
The Bollinger Bands (100) for Blueprint Medicines is (88.27 - 104.19), which suggest Blueprint Medicines is a Sell
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.